Background: Angiotensin 1 converting enzyme (ACE) inhibitors reduce morbidity and mortality after coronary artery bypass graft surgery (CABG). This benefit may result from an anti-inflammatory action.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback